Tacrine (Hydrochloride)

L-type calcium channel inhibitor; Inhibits acetylcholinesterase and butyrylcholinesterase

Tacrine (Hydrochloride)

L-type calcium channel inhibitor; Inhibits acetylcholinesterase and butyrylcholinesterase

From: 209 USD
Catalog #
(Select a product)
L-type calcium channel inhibitor; Inhibits acetylcholinesterase and butyrylcholinesterase
Add to Wish List

Overview

Tacrine potently inhibits acetylcholinesterase and butyrylcholinesterase (IC50 = 31 and 26.5 nM, respectively; Ahmed et al.). It also inhibits both human and rat histamine-N-methyltransferase in a dose-dependent manner (Taraschenko et al.). Tacrine is used in the treatment of Alzheimer's disease (Ahmed et al.; McKenna et al.; Taraschenko et al.).

DISEASE MODELING
· Inhibits L-type calcium channels and decreases the influx of calcium in mouse neurons (Dolezal et al.).
Alternative Names
C.I. 970; Hydroaminacrine
Cell Type
Neurons
Area of Interest
Disease Modeling, Neuroscience
CAS Number
1684-40-8
Chemical Formula
C13H14N2 • HCl
Molecular Weight
234.7 g/mol
Purity
≥ 98%
Pathway
L-type Calcium Channel
Target
L-type Calcium Channel

Protocols and Documentation

Find supporting information and directions for use in the Product Information Sheet or explore additional protocols below.

Document Type
Product Name
Catalog #
Lot #
Language
Catalog #
100-0888
Lot #
All
Language
English
Document Type
Safety Data Sheet
Catalog #
100-0888
Lot #
All
Language
English